Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,830,159
-
Share change
-
+33,340,671
-
Total reported value
-
$441,370,000
-
Price per share
-
$12.68
-
Number of holders
-
46
-
Value change
-
+$422,483,000
-
Number of buys
-
43
Institutional Holders of THESEUS PHARMACEUTICALS INC - COM (THRX) as of Q4 2021
As of 31 Dec 2021,
THESEUS PHARMACEUTICALS INC - COM (THRX) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,830,159 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Foresite Capital Management V, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Omega Fund Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, Nextech Invest AG, and BlackRock Inc..
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.